Market Place
Sourcing Support
Neurelis Shares Valtoco® Study Design for Ages 2-5 at CNS Meeting
11 Nov 2024 //
PR NEWSWIRE
Aquestive Therapeutics Reports Q2 2024 Results And Business Update
06 Aug 2024 //
GLOBENEWSWIRE
FDA Confirms Para IV Patent Litigation for Diazepam (Valtoco) Nasal Spray
26 Apr 2024 //
FDA
Aquestive: Libervant Crossover Data At AAN 2024
12 Apr 2024 //
GLOBENEWSWIRE
Neurelis AAN Posters On Epilepsy, Movement Disorders
11 Apr 2024 //
PR NEWSWIRE
Neurelis Secures New Orange Book Listed U.S. Patent For Valtoco
27 Nov 2023 //
PR NEWSWIRE
Aculys delivers positive Phase 3 study interim analysis result of a diazepam
18 Oct 2023 //
PR NEWSWIRE
Neurelis To Present Analyses Of Valtoco Civ at the Annual Meeting
04 Oct 2023 //
PR NEWSWIRE
Aquestive Therapeutics Receives FDA Acceptance of NDA for Libervant
11 Sep 2023 //
GLOBENEWSWIRE
Neurelis To Present Analyses Of Valtoco Civ Highlighting Effects
31 Aug 2023 //
PR NEWSWIRE
Aquestive Provides Business Update and Announces CMO Appointment
29 Jun 2023 //
GLOBENEWSWIRE
Lupin gets US FDA approval for Diazepam Rectal Gel
02 Jun 2023 //
CNBCTV18
Novel `s Generic Diazepam Receives Receives Approval in the U.S.
30 May 2023 //
FDA
Aquestive Expands Libervant License/Supply Agreement with Pharmanovia
29 Mar 2023 //
CONTRACT PHARMA
Fresenius`s Generic Diazepam Receives Approval in the U.S.
09 Nov 2022 //
FDA
Neurelis Presents Novel, Investigational Analysis Of Valtoco Civ at Meeting
13 Oct 2022 //
PRNEWSWIRE
Neurelis Presents Novel, Investigational Analysis Of VALTOCO
13 Oct 2022 //
BIOSPACE
Neurelis Announces Presentation Of Analysis TimeBetween Seizure Clusters VALTOCO
12 Oct 2022 //
PRNEWSWIRE
Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia
28 Sep 2022 //
GLOBENEWSWIRE
Study Published In Epilepsia Shows Intervals Between Seizure Clusters Treated
07 Sep 2022 //
PRNEWSWIRE
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™
31 Aug 2022 //
PRESS RELEASE
New Quality Of Life Data For Valtoco CIV In Seizure Clusters Published
20 Jul 2022 //
PRNEWSWIRE
Enforcement Report - Week of February 23, 2022
23 Feb 2022 //
FDA
NEURELIS SIGNS EXCLUSIVE LICENSING AGREEMENT WITH ACULYS PHARMA FOR VALTOCO
25 Jan 2022 //
PRNEWSWIRE
Supply Disruption Alert: Diazepam RecTubes 2.5mg Rectal Solution (Wockhardt UK)
11 Oct 2021 //
PSNC
Aquestive Therapeutics Resubmits New Drug Application for Libervant Buccal Film
24 Jun 2021 //
GLOBENEWSWIRE
Neurelis Announces National Wholesale And Retailer Chains And Independent
09 Nov 2020 //
PRNEWSWIRE
Xeris Granted Fast Track Designation by the FDA for Diazepam (XP-0863)
20 Oct 2020 //
BIOSPACE
Neurelis Announces FDA Approval Of Extended Expiration Dating For VALTOCO®
19 Oct 2020 //
PRNEWSWIRE
Neurelis Announces Four Poster Presentations For The Joint Meeting
16 Oct 2020 //
PRNEWSWIRE
Aquestive Receives Complete Response Letter from FDA for Libervant™ (diazepam)
25 Sep 2020 //
SEEKING ALPHA
Neurelis Announces Rapid and Broad Payer Coverage of the Company`s Flagship
08 Jun 2020 //
PRNEWSWIRE
Neurelis Announces Total Of Nine Poster Presentations For The AANN, AMCP
20 May 2020 //
PRNEWSWIRE
Xeris`s Announces +ve Topline Results From a Study of Its Diazepam
20 Apr 2020 //
BIOSPACE
diazepam nasal spray illustrates FDA parameters for orphan drug exclusivity
14 Jan 2020 //
END PTS
‘Clinical Superiority’FDA Finds Diazepam Nasal Spray Deserves Orphan Exclusivity
13 Jan 2020 //
RAPS
Beloteca`s Generic Diazepam Receives Approval in US
27 Dec 2019 //
FDA
Seizures of black market diazepam tablets double in the UK in a year
05 Dec 2019 //
PHARMA FILE
Emergent Bio nabs $20M from DoD to develop diazepam auto-injector
26 Sep 2019 //
SEEKINGALPHA
Neurelis debuts seizure awareness campaign
24 May 2019 //
FIERCE BIOTECH
Beloteca Inc `s Generic Diazepam Receives Approval in US
21 Mar 2019 //
FDA
Steep Climb In Benzodiazepine Prescribing By Primary Care Doctors
28 Jan 2019 //
NPR
Aquestive Therapeutics` Progress of CNS Assets, Financial and Legal Matters
20 Dec 2018 //
PR NEWSWIRE
NCB busts Gurgaon-based online pharmacy for shipping illegal drugs
06 Aug 2018 //
ECONOMIC TIMES
Lawmaker urges Pfizer to sue over lethal injection procedure
30 Jul 2018 //
FIERCE PHARMA
Pfizer demands return of drugs set for use in US lethal injections
22 Nov 2017 //
IN PHARMATECHNOLOGY
Pfizer in fight with states over their intent to use its drugs for executions
21 Nov 2017 //
FIERCE PHARMA
Nevada refusing Pfizer demand for return of execution drugs
17 Nov 2017 //
THE STATE
Second valium manufacturer Arrow recalls medication after fears of tampering
09 Jun 2017 //
SMH
Roche recalls Valium in Australia after tampering uncovered
02 Jun 2017 //
FIERCE PHARMA
Roche is recalling all batches of Valium & Apotex Recall 3 Batch Product
27 May 2017 //
AJP
MonoSol Rx Appoints John T. Maxwell as Chief Financial Officer
25 Jan 2017 //
GLOBENEWSWIRE
MonoSol Receives FDA Orphan Drug Designation for Diazepam
30 Nov 2016 //
GLOBENEWSWIRE
Investors Upset as Acorda Abandons Development of Another Drug After PhII Flop
22 Nov 2016 //
BIOSPACE
Ganaxolone & Diazepam Administered I.V. Block Seizures in Animal Model
15 Nov 2016 //
GLOBENEWSWIRE
Lannett Receives FDA Approval For Diazepam Oral Solution, 5 mg/5 mL
28 Jun 2016 //
PR NEWSWIRE
Rusan Pharma Ltd fails EDQM Inspection
04 Apr 2016 //
EDQM
Benzodiazepine prescriptions, overdose deaths on the rise in U.S.
26 Feb 2016 //
REUTERS
Neurelis Finalizes Series A Financing to Advance Lead Program to NDA Filing
22 Feb 2016 //
PR NEWSWIRE
